WALTHAM, Mass. , Nov. 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, today announced that management will participate
- Q3 revenue of $21.3 million , increasing 30% year-over-year - Q3 gross profit increased 37% year-over-year to $13 .4 million with a gross margin of 63% - Won 5 DAAP deals during Q3 WALTHAM, Mass. , Nov. 13, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading
WALTHAM, Mass. , Oct. 31, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Wednesday, November
WALTHAM, Mass. , Sept. 10, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced an expansion of a strategic
The availability of Micro-Neighborhood ® Targeting on the Company’s Dynamic Audience Activation Platform meets the demand of life sciences marketers by synchronizing consumer and physician marketing OptimizeRx presents panel session at Digital Pharma East: Unlocking Opportunity through HCP+DTC
– Q2 revenue of $18.8 million , increasing 36% year-over-year – Q2 gross profit increased 50% year-over-year to $11 .7 million with a gross margin of 62% – Won 8 DAAP deals during Q2 WALTHAM, Mass. , Aug. 08, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp.
WALTHAM, Mass. , July 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Thursday, August
OptimizeRx Micro Neighborhood® Targeting enables pharmaceutical brands to maintain and expand campaign scale nationwide WALTHAM, Mass. , July 23, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences
The Company’s AI-guided predictive targeting platform delivered three times the return in half the time of the traditional trigger-based program WALTHAM, Mass. , July 15, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions
• 84% of Patients Arrive at Doctor Visits Underinformed • Underscores Growing Importance of HCP and DTC Alignment in Pharma Commercialization and Marketing Strategies • OPRX Closes First Combined HCP and DTC DAAP Marketing Program for Top 5 Pharma Client WALTHAM, Mass.
